Abstract
The pharmaceutical industry is an important part of our national economy, which is the combination of traditional industry and modern industry. Medicine is an industry with high technology, high risk, high investment and high return, and has always been the focus of competition in developed countries. If Chinese pharmaceutical enterprises want to stand out in such fierce competition, they must find out the core competitiveness that fits their own development path. Based on the construction of the evaluation index system of the core competitiveness of the pharmaceutical industry, this study makes an empirical analysis of Hengrui pharmaceutical based on the fuzzy comprehensive evaluation method, discusses the reasons for the formation of its core competitiveness, and puts forward effective ways for listed companies in the pharmaceutical industry to enhance their core competitiveness.
Keywords
Get full access to this article
View all access options for this article.